"A drug that takes advantage of cancer cells's appetite for the vitamin folate helped keep lung cancer at bay in 30 percent of patients with advanced disease, the chief executive of Endocyte said on Monday."
Read more:
http://www.iol.co.za/index.php?set_id=1&click_id=117&art_id=nw20090811093249211C692312
No comments:
Post a Comment